Radioembolization for hepatocellular carcinoma: what clinicians need to know

Transarterial radioembolization (TARE) with yttrium 90 ((90)Y) has been used in the management of hepatocellular carcinoma (HCC) for more than 10 years in Korea. There are two types of (90)Y radioactive microspheres available, namely, glass and resin microspheres, with comparable clinical outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jin Woo, Kim, Hyo-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Liver Cancer Association 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035707/
https://www.ncbi.nlm.nih.gov/pubmed/37383534
http://dx.doi.org/10.17998/jlc.2022.01.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035707/
https://www.ncbi.nlm.nih.gov/pubmed/37383534
http://dx.doi.org/10.17998/jlc.2022.01.16

Ejemplares similares